Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-25-107606
Filing Date
2025-11-07
Accepted
2025-11-07 16:00:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 27239
  Complete submission text file 0001213900-25-107606.txt   29039
Mailing Address 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA 94043
Business Address 455 N. BERNARDO AVENUE MOUNTAIN VIEW CA 94043 6502372700
NeuroPace Inc (Subject) CIK: 0001528287 (see all company filings)

EIN.: 223550230 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-92504 | Film No.: 251462439
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830
Business Address C/O SOLEUS PRIVATE EQUITY GP I, LLC 104 FIELD POINT ROAD, 2ND FLOOR GREENWICH CT 06830 475-208-3178
Soleus Private Equity Fund I, L.P. (Filed by) CIK: 0001752427 (see all company filings)

EIN.: 824521410 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A